Fresenius Kabi
Carina M. has extensive experience in the pharmaceutical industry, with a strong focus on biosimilars and gynecology products. Currently serving as Sales and Marketing Manager for Biopharma at Fresenius Kabi, Carina oversees the Biosimilars product portfolio in Sweden and Finland. Previous roles include Product and Sales Manager for the launch of Fresenius Kabi's biosimilars, and Nordic Product Manager for haemophilia at PharmaRelations. Carina has also held key positions at Pfizer as Country Portfolio Lead for biosimilars and at Orion Corporation managing branded generics and biosimilars. With a career spanning over three decades, Carina's expertise encompasses strategic marketing, sales leadership, and product management across various therapeutic areas. Education includes a Business Economist degree from IHM Business School and additional training from Mercuri International.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.